Fay Lui, | |
605 Fletcher Pkwy, El Cajon, CA 92020-2522 | |
(619) 440-0848 | |
(619) 440-4047 |
Full Name | Fay Lui |
---|---|
Gender | Female |
Speciality | Pharmacist |
Location | 605 Fletcher Pkwy, El Cajon, California |
Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1013325521 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
183500000X | Pharmacist | 49342 (California) | Primary |
Mailing Address | Practice Location Address |
---|---|
Fay Lui, 605 Fletcher Pkwy, El Cajon, CA 92020-2522 Ph: (619) 440-0848 | Fay Lui, 605 Fletcher Pkwy, El Cajon, CA 92020-2522 Ph: (619) 440-0848 |
News Archive
Cerus Corporation announced today that its Phase 1 trial of red blood cells treated with the INTERCEPT Blood System met its primary endpoint, with preliminary analysis demonstrating that greater than 75 percent of treated cells continued to circulate 24 hours following transfusion. The INTERCEPT red blood cell system is a pathogen inactivation treatment the company is developing to protect against transmission of infectious diseases through red blood cell transfusions. An estimated 70 million units of red blood cells are transfused worldwide each year.
Celtic Therapeutics Holdings L.P. a successor firm to Celtic Pharma, and Resolvyx Pharmaceuticals, Inc. (Resolvyx) announced today that they have entered into an option agreement relating to Resolvyx's RX-10045, a late-stage program for the treatment of dry eye syndrome and other ophthalmic conditions.
Compared to peers at public schools, adolescents who are homeschooled are more likely to report greater character strengths and fewer risky health behaviors later in life, but are less likely to attain a college degree, according to a new study published this week in the open-access journal PLOS ONE by Tyler VanderWeele of Harvard T.H. Chan School of Public Health, US, and colleagues.
NeuroSigma, Inc., a Los Angeles-based medical device company, today announced it has been awarded a Phase I NIH-STTR grant from the National Institute of Neurological Disorders and Stroke (NINDS) for the further development of its Thin-Film Nitinol (TFN)-covered stent for the potential treatment of brain aneurysms.
› Verified 6 days ago
Nada Ghaith, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 11981 Via Hacienda, El Cajon, CA 92019 Phone: 619-277-0331 | |
Claire Huynh, PHARM.D Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 2911 Jamacha Rd, El Cajon, CA 92019 Phone: 619-315-0016 | |
Lana Dalal, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: Walmart Pharmacy# 3524,605 Fletcher Pkwy, El Cajon, CA 92020 Phone: 619-440-0848 | |
Hani Maroki, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1000 S Mollison Ave Unit 15, El Cajon, CA 92020 Phone: 619-792-8610 | |
Kwi Yeom Lee, PHARM.D. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 300 N 2nd St, El Cajon, CA 92021 Phone: 619-219-5252 | |
Mr. Charles Harold Jones, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 2899 Jamacha Rd, El Cajon, CA 92019 Phone: 858-405-8377 |